Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancerGiampietro Gasparini, Dino Amadori, Luigi Mariani et al.|Breast Cancer Research and Treatment|2006Cited by 140